New antibiotics need new partnerships
09 October 2009
Ian Schofield
Please Login to read the full article.
09 October 2009
Ian Schofield
Infections are fast becoming the new neglected diseases. As antibiotics lose their effectiveness against serious bacterial illnesses because of the rise in resistant pathogens, the likelihood is growing that common treatable conditions such as pneumonia and tuberculosis will again become fatal diseases...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Rib-X Pharma files for IPO to finance antibiotics providing superior coverage
- IMI plans "unprecedented" programme for novel antibiotics as drug resistance continues to rise
- US bill aims to provide exclusivity, other incentives for antibiotic makers
- Rib-X inks potentially lucrative deal with Sanofi for new class of antibiotics
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
